Cargando…
Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia
BACKGROUND: Effective prophylactic vaccines are available against human papillomavirus (HPV) types 6, 11, 16, and 18 which are licensed for routine use among young women. Monitoring is needed to demonstrate protection against cervical cancer, to verify duration of protection, and assess replacement...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841185/ https://www.ncbi.nlm.nih.gov/pubmed/20222944 http://dx.doi.org/10.1186/1471-2334-10-63 |